Brain boost? Mitochondrial support? Longevity tool? Here’s what you actually need to know. Methylene blue has been around for well over 100 years, but lately it has exploded in the longevity and biohacking world. So what exactly is it? 🔵 Methylene blue is a synthetic compound and medication — NOT a peptide. Its established medical use includes treating acquired methemoglobinemia, a condition in which hemoglobin can't effectively deliver oxygen to tissues. But the reason you're hearing about it in the wellness world is very different: 🧠 Why are people interested in it? Researchers have studied methylene blue's effects on mitochondrial energy metabolism and the brain. At low concentrations, laboratory and preclinical research suggests it can participate in electron transfer within mitochondria—the little “power plants” inside our cells. That's where the interest in energy, cognition, memory and neuroprotection comes from. There is some human research too. One small randomized, double-blind study involving 26 healthy adults investigated a single low oral dose and found changes in brain activity associated with attention and memory, along with improved memory retrieval. Interesting? Yes. Proof that taking methylene blue long-term prevents cognitive decline or acts as a longevity drug? No. And larger Alzheimer's research using a related form of the methylene-blue molecule has not demonstrated the clear benefit people sometimes imply online. A Phase 3 trial involving 891 people did not meet its primary efficacy outcomes when the treatment was added to standard Alzheimer's medications. 🚨 THIS PART MATTERS: Who should NOT casually take it? Methylene blue can act as a monoamine oxidase (MAO) inhibitor, which means medication interactions can become serious. ⚠️ SSRIs/SNRIs and other serotonergic antidepressants ⚠️MAO inhibitors ⚠️Certain opioids ⚠️Dextromethorphan— found in many cough medicines ⚠️ Other medications that increase serotonin Combining methylene blue with serotonergic drugs can potentially cause serotonin syndrome, which can be life-threatening. The current prescription label carries a boxed warning about this interaction.

I tried Methylene Blue and Holy Smokes is all I can say! My energy level and focus has drastically changed in a positive way. I’m so grateful for this community ❤️

🩷 BLUEPRINT SPOTLIGHT: ATX-304 What if metabolic research could target energy expenditure—not just appetite? Most of the weight-loss conversation right now revolves around eating less. ATX-304 is interesting because researchers are looking at a completely different lever: how the body uses energy. ATX-304 is an investigational small molecule—not a peptide—designed to activate the AMPK energy-sensing network and affect mitochondrial metabolism. Think of AMPK as one of the body's cellular “energy managers,” responding when energy demand increases. 🔬 Why is everyone suddenly talking about it? In a small Phase 1b study of adults with obesity and prediabetes, researchers reported improvements in measures including: ⚡ Resting metabolic rate 🔥 Visceral fat 🫀 Liver fat 🩸 Triglycerides 🔄 Adiponectin Importantly, the study was small—only 23 participants—and lasted 8 weeks for the randomized portion, so this is nowhere near enough evidence to call ATX-304 a proven weight-loss treatment. 🤔 Where it gets REALLY interesting… Researchers are also investigating whether ATX-304 could eventually complement incretin drugs such as GLP-1 therapies. The theory is interesting: GLP-1 → primarily targets food intake/appetite ATX-304 → being studied for energy utilization/expenditure Animal research combining ATX-304 with semaglutide has produced intriguing findings around weight regain and lean mass—but those results were in mice, not humans. 🧠 THE BLUEPRINT TAKEAWAY ATX-304 represents something I think we're going to hear much more about: Moving beyond “How do we eat less?” toward “Can we change how the body uses energy?” Promising? Interesting enough to watch. Proven? Not yet. ATX-304 remains investigational and is not an FDA-approved obesity treatment. Human research is still early. 💬 Would you want me to do a deeper ATX-304 breakdown comparing it with GLP-1s, MOTS-C and other metabolic compounds? Consult • Educate • Empower 🩷 The AgeWell Blueprint Lab Research: American Diabetes Association, 2026 Phase 1b ATX-304 report; Cambrian Bio ATX-304 clinical-development program; Journal of the Endocrine Society, 2025 preclinical combination study.

IN THE VAULT NOT ONLY IS THERE A FULL COMPOUND LIBRARY BUT A REVERSE CALCULATOR! Who needs this? Let's say you have vial X but then you get vial X again in a different mg? How do you figure out what your dosing is with a different mg vial if you do not even know what dose you were at because units on the syringe is all you use to decipher the amount to take? The DOSE-UNIT calculator allows you to put in the units to then give you the actual dose. Soooo then you take that dose and put it into the COMPOUND LIBRAY with the new vial and bac water to calculate your UNITS! HOPE THIS MAKES SENSE AND HELPS EVERYONE TO LEARN WHAT DOSE YOU ARE TAKING!!

Why Retatrutide May Feel Slower at First “I started Reta and the scale isn't moving like it did on Tirz or Sema.” I hear this a lot. But here's something important to understand: 💧 Early scale loss ≠ all body-fat loss When food intake drops significantly, your body uses stored glycogen (carbohydrate stored in your liver and muscles). Glycogen holds water. Use glycogen → lose some associated water → scale drops. That's one reason the first few weeks on a weight-loss medication can look dramatic. It doesn't mean every pound lost was body fat. 🧬 What makes Retatrutide different? Semaglutide targets GLP-1. Tirzepatide targets GLP-1 + GIP. Retatrutide targets GLP-1 + GIP + glucagon receptors — which is why it's called a triple agonist. That third glucagon-receptor pathway is one reason researchers are so interested in Reta's potential effects on energy balance and metabolism. BUT: we don't currently have evidence showing that Reta simply “burns more fat” while Sema/Tirz mainly cause water loss. That's an oversimplification. 📏 So don't judge Month 1 by the scale alone. Track: ⚖️ Weight trends — not one day's number 📏 Waist circumference 👖 How your clothes fit 💪 Strength + muscle preservation 🥩 Protein and overall nutrition And remember: faster scale loss isn't automatically better fat loss. One more thing—when appetite drops dramatically, nutrition can drop with it. Protein, hydration and adequate micronutrient intake still matter. 💗 The Blueprint Takeaway Don't chase the dramatic first-month number. Chase sustainable changes in body composition, nutrition and metabolic health. Save this one for the next time the scale makes you think “this isn't working.” Educational content only. Retatrutide remains investigational and is not FDA-approved. Research: Lee et al., Horm Metab Res (2026) • Simancas-Racines et al., Obes Pillars (2026) • Bijoch, J Clin Med(2026)